Free Trial

Lexeo Therapeutics (LXEO) Insider Trading & Ownership

Lexeo Therapeutics logo
$7.78 +0.14 (+1.83%)
(As of 11/14/2024 ET)

Lexeo Therapeutics (NASDAQ:LXEO) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
4.50%
Number Of
Insiders Buying
(Last 12 Months)
0
Number Of
Insiders Selling
(Last 12 Months)
1
Amount Of
Insider Selling
(Last 12 Months)
$615,938.50
Get LXEO Insider Trade Alerts

Want to know when executives and insiders are buying or selling Lexeo Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

LXEO Insider Buying and Selling by Quarter

Lexeo Therapeutics Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
11/11/2024Richard Nolan TownsendCEOSell2,500$7.82$19,550.00  
10/10/2024Richard Nolan TownsendCEOSell5,000$8.10$40,500.00  
9/10/2024Richard Nolan TownsendCEOSell5,000$10.65$53,250.00  
8/12/2024Richard Nolan TownsendCEOSell5,000$11.53$57,650.00  
7/10/2024Richard Nolan TownsendCEOSell26,969$16.50$444,988.50  
(Data available from 1/1/2013 forward)

LXEO Insider Trading Activity - Frequently Asked Questions

The list of insiders at Lexeo Therapeutics includes Fund Vi L.P. Omega, and Richard Nolan Townsend. Learn more on insiders at LXEO.

4.50% of Lexeo Therapeutics stock is owned by insiders. Learn more on LXEO's insider holdings.

The following insider purchased LXEO shares in the last 24 months: Fund Vi L.P. Omega ($4,999,995.00).

Insiders have purchased a total of 454,545 LXEO shares in the last 24 months for a total of $4,999,995.00 bought.

The following insider sold LXEO shares in the last 24 months: Richard Nolan Townsend ($615,938.50).

Insiders have sold a total of 44,469 Lexeo Therapeutics shares in the last 24 months for a total of $615,938.50 sold.

Lexeo Therapeutics Key Executives

  • Mr. R. Nolan Townsend (Age 43)
    CEO & Director
    Compensation: $864.34k
  • Dr. Eric Adler M.D. (Age 50)
    Chief Medical Officer & Head of Research
    Compensation: $623.4k
  • Ms. Jenny R. Robertson (Age 49)
    Chief Business & Legal Officer
    Compensation: $617.9k
  • Dr. Ronald G. Crystal M.D.
    Co-Founder, Chief Scientific Advisor & Member of Scientific Advisory Board
  • Dr. Paul B. McCormac Ph.D. (Age 54)
    Chief Technical Officer
    Compensation: $471.73k
  • Dr. Jordan Shin M.D.
    Ph.D., Senior Vice President of Clinical Development & Translational Science, Cardiology
  • Dr. Jordan S. Dubow M.D. (Age 45)
    Head of CNS Clinical Development
  • Dr. Sandi See Tai M.D. (Age 53)
    Chief Development Officer
  • Mr. Ryan McHenry
    VP & Corporate Controller


This page (NASDAQ:LXEO) was last updated on 11/14/2024 by MarketBeat.com Staff
From Our Partners